Skip to contentC
China Pharma Holdings, Inc.
C
CPHIChina Pharma Holdings, Inc. Q1 2017 · 10-Q
Revenue$3.29M$3.29M−9.8% vs Q1 2016 Net Income-$966.90K-$966.90KN/M vs Q1 2016 EPS Diluted-$0.02-$0.02N/M vs Q1 2016 Gross Profit$717,853+12.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
China Pharma Holdings, Inc. · CIK 1106644 · Engraved from SEC EDGAR
Operating Cash Flow$9,764−99.3% Free Cash Flowderived-$16,864N/M Margins · derivedGross margin21.9%+4.2 pt vs Q1 2016
Operating margin-24.4%+11.9 pt vs Q1 2016
Net margin-29.4%+13.2 pt vs Q1 2016
ended Mar 31, 2017 · filed May 11, 2017 · 41 d after period end